Cytodyn Inc (CYDY) financial statements (2021 and earlier)

Company profile

Business Address 1111 MAIN STREET, SUITE 660
VANCOUVER, WA 98660
State of Incorp. DE
Fiscal Year End May 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2914312101
Cash and cash equivalents2914312101
Restricted cash and investments 01    
Inventory, net of allowances, customer advances and progress billings99      
Inventory99      
Prepaid expense1000000
Other undisclosed current assets12222421
Total current assets:13137536112
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000000
Intangible assets, net (including goodwill)1213152223
Intangible assets, net (excluding goodwill)1213152223
Total noncurrent assets:1314162223
TOTAL ASSETS:144512158145
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities65381817425
Accounts payable46291616425
Accrued liabilities   0   
Employee-related liabilities16721   
Interest and dividends payable310    
Debt  4 1 (0)
Other undisclosed current liabilities51750116
Total current liabilities:1164527176411
Noncurrent Liabilities
Long-term debt and lease obligation080    
Long-term debt, excluding current maturities 80    
Operating lease, liability00
Liabilities, other than long-term debt34 213 2
Accounts payable and accrued liabilities34      
Derivative instruments and hedges, liabilities  213 2
Other undisclosed noncurrent liabilities (0)    3
Total noncurrent liabilities:358313 5
Total liabilities:1505330189415
Stockholders' equity
Stockholders' equity attributable to parent, including:(7)(2)(9)(13)(1)10(11)
Preferred stock   0000
Common stock11000036
Treasury stock, value (0)(0)(0)   
Additional paid in capital41435222016012210725
Accumulated deficit(422)(355)(229)(173)(123)(97)(72)
Other undisclosed stockholders' equity attributable to parent 00    
Total stockholders' equity:(7)(2)(9)(13)(1)10(11)
TOTAL LIABILITIES AND EQUITY:144512158145

Income statement (P&L) ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Gross profit:11     
Operating expenses(100)(75)(56)(46)(27)(21)(20)
Operating loss:(99)(74)(56)(46)(27)(21)(20)
Nonoperating income (expense)(1)022210
Investment income, nonoperating(1)02221(1)
Debt instrument, convertible, beneficial conversion feature      1
Interest and debt expense(23)(18)(5)(6)(1)(5)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes      0
Loss from continuing operations before equity method investments, income taxes:(123)(92)(59)(50)(26)(26)(25)
Other undisclosed loss from continuing operations before income taxes(36)(32)     
Loss from continuing operations before income taxes:(159)(124)(59)(50)(26)(26)(25)
Income tax benefit  3    
Net loss available to common stockholders, diluted:(159)(124)(56)(50)(26)(26)(25)

Comprehensive Income ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Net loss:(159)(124)(56)(50)(26)(26)(25)
Comprehensive loss, net of tax, attributable to parent:(159)(124)(56)(50)(26)(26)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: